Search trials for
Showing NN of NN trials
Enrolling

A Study of E6011 in Participants With Active Crohn's Disease

The primary purpose of this study is to examine the efficacy and safety of E6011 after administration by means of...

Enrolling

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Mo...

The purpose of this study is to evaluate the efficacy and safety of SHP647 in inducing clinical remission and endoscopic...

Want more information about clinical trials near you?

Register to get notifications about clinical trials in your area.
Register to Receive Updates
Enrolling

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

The proposed study is a randomized, double-blind, placebo-controlled, multi-center Phase II study to investigate the safety and efficacy of SHR0302...

Enrolling

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Mo...

The purpose of this study is to evaluate the efficacy and safety of SHP647 in inducing clinical remission and endoscopic...

Enrolling

An Investigational Study of Experimental Medication BMS-986165 in Participants W...

This is an investigational study, also known as LATTICE-CD, of the experimental medication BMS-986165 in participants with moderate to severe...

Enrolling

Efficacy and Safety of Oral OPS-2071 in Subjects With Crohn's Disease Showing Sy...

The purpose of this study is the effects, safety and how OPS-2071 (150, 300, or 600 mg twice a day...

Enrolling

Reduce Risk for Crohn's Disease Patients

The purpose of this study is to compare the effectiveness of weekly subcutaneously administered Methotrexate for maintaining relapse-free sustained steroid/Enteral...

Enrolling

Vedolizumab Subcutaneous Long-Term Open-Label Extension Study

The purpose of this study is to obtain long term safety and tolerability data of vedolizumab subcutaneous (vedolizumab SC) in...

Enrolling

A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Pa...

This is a multicenter, Phase 3, double-blind, placebo-controlled study evaluating the efficacy, safety, and tolerability of etrolizumab compared with placebo...